Early Stage HER2-Positive Breast Cancers Not Achieving a pCR From Neoadjuvant Trastuzumab- or Pertuzumab-Based Regimens Have an Immunosuppressive Phenotype
Titel:
Early Stage HER2-Positive Breast Cancers Not Achieving a pCR From Neoadjuvant Trastuzumab- or Pertuzumab-Based Regimens Have an Immunosuppressive Phenotype
Auteur:
Force, Jeremy Howie, Lynn J. Abbott, Sara E. Bentley, Rex Marcom, P. Kelly Kimmick, Gretchen Westbrook, Kelly Sammons, Sarah L. Parks, Michelle Topping, Donna L. Emerson, Ryan Broadwater, Gloria Hyslop, Terry Blackwell, Kimberly L. Nair, Smita K.